{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T13:15:28Z","timestamp":1721826928489},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,1]]},"DOI":"10.7759\/cureus.48115","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T18:30:16Z","timestamp":1698863416000},"source":"Crossref","is-referenced-by-count":1,"title":["Frequency of Painful Crisis and Other Associated Complications of Sickle Cell Anemia Among Children"],"prefix":"10.7759","author":[{"given":"Jana S","family":"Sendy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed S","family":"Alsadun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah S","family":"Alamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujon M","family":"Alazzam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansour M","family":"Alqurashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel H","family":"Almudaibigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0256-4947.81540","article-title":"Epidemiology of sickle cell disease in Saudi Arabia","volume":"31","author":"Jastaniah W","year":"2011","unstructured":"Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med. 2011, 31:289-93. 10.4103\/0256-4947.81540","journal-title":"Ann Saudi Med"},{"key":"ref2","unstructured":"What is sickle cell disease?. (2022). Accessed. June 21, 2023: https:\/\/www.nhlbi.nih.gov\/health\/sickle-cell-disease."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1922.02640160038012","article-title":"Sickle cell anemia, severe anemia with remarkable elongated shaped red blood cells","volume":"79","author":"Masom VR","year":"1922","unstructured":"Masom VR. Sickle cell anemia, severe anemia with remarkable elongated shaped red blood cells. JAMA. 1922, 79:1318-20. 10.1001\/jama.1922.02640160038012","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith WR","year":"2008","unstructured":"Smith WR, Penberthy LT, Bovbjerg VE, et al.. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med. 2008, 148:94-101. 10.7326\/0003-4819-148-2-200801150-00004","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2007.CDC4","article-title":"Sickle cell disease: current activities, public health implications, and future directions","volume":"16","author":"Creary M","year":"2007","unstructured":"Creary M, Williamson D, Kulkarni R. Sickle cell disease: current activities, public health implications, and future directions. J Womens Health (Larchmt). 2007, 16:575-82. 10.1089\/jwh.2007.CDC4","journal-title":"J Womens Health (Larchmt)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1179\/136485907X154638","article-title":"Sickle cell disease in Africa: burden and research priorities","volume":"101","author":"Makani J","year":"2007","unstructured":"Makani J, Williams TN, Marsh K. Sickle cell disease in Africa: burden and research priorities. Ann Trop Med Parasitol. 2007, 101:3-14. 10.1179\/136485907X154638","journal-title":"Ann Trop Med Parasitol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jegh.2011.06.002","article-title":"Marked regional variations in the prevalence of sickle cell disease and \u03b2-thalassemia in Saudi Arabia: findings from the premarital screening and genetic counseling program","volume":"1","author":"Memish ZA","year":"2011","unstructured":"Memish ZA, Owaidah TM, Saeedi MY. Marked regional variations in the prevalence of sickle cell disease and \u03b2-thalassemia in Saudi Arabia: findings from the premarital screening and genetic counseling program. J Epidemiol Glob Health. 2011, 1:61-8. 10.1016\/j.jegh.2011.06.002","journal-title":"J Epidemiol Glob Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.1998.293","article-title":"Sickle cell disease in childhood in Madina","volume":"18","author":"Hawasawi ZM","year":"1998","unstructured":"Hawasawi ZM, Nabi G, Al Magamci MS, Awad KS. Sickle cell disease in childhood in Madina. Ann Saudi Med. 1998, 18:293-5. 10.5144\/0256-4947.1998.293","journal-title":"Ann Saudi Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel FB","year":"2017","unstructured":"Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017, 376:1561-73. 10.1056\/NEJMra1510865","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12440","article-title":"Risk factors and complications among pediatric patients with sickle cell anemia: a single tertiary center retrospective study","volume":"13","author":"Alzahrani F","year":"2021","unstructured":"Alzahrani F, Fallatah AM, Al-Haddad FM, Khayyat ST, AlMehmadi WM, AlQahtani BG, Alamri RS. Risk factors and complications among pediatric patients with sickle cell anemia: a single tertiary center retrospective study. Cureus. 2021, 13:e12440. 10.7759\/cureus.12440","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.21767\/2386-5180.1000226","article-title":"Prevalence of complications of sickle cell disease at Makkah Al-Mukaramah, Saudi Arabia","volume":"6","author":"Alkot M","year":"2017","unstructured":"Alkot M, Almaghrabi WA, Al Najdi N, Al Otaib M, Shatla M, Abdelbaki H. Prevalence of complications of sickle cell disease at Makkah Al-Mukaramah, Saudi Arabia. Ann Clin Lab Res. 2017, 6:1-5. 10.21767\/2386-5180.1000226","journal-title":"Ann Clin Lab Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2019.4.24049","article-title":"Causes of hospitalization in sickle cell diseased children in western region of Saudi Arabia. A single center study","volume":"40","author":"Abd Elmoneim AA","year":"2019","unstructured":"Abd Elmoneim AA, Al Hawsawi ZM, Mahmoud BZ, Bukhari AA, Almulla AA, Sonbol AM, Makhdoum AM. Causes of hospitalization in sickle cell diseased children in western region of Saudi Arabia. A single center study. Saudi Med J. 2019, 40:401-4. 10.15537\/smj.2019.4.24049","journal-title":"Saudi Med J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S318824","article-title":"Analysis of causes of hospitalization among children with sickle cell disease in a group of private hospitals in Jeddah, Saudi Arabia","volume":"12","author":"Abd El-Ghany SM","year":"2021","unstructured":"Abd El-Ghany SM, Tabbakh AT, Nur KI, Abdelrahman RY, Etarji SM, Almuzaini BY. Analysis of causes of hospitalization among children with sickle cell disease in a group of private hospitals in Jeddah, Saudi Arabia. J Blood Med. 2021, 12:733-40. 10.2147\/JBM.S318824","journal-title":"J Blood Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2020.1.24698","article-title":"The role of hydroxyurea in decreasing the occurrence of vasso-occulusive crisis in pediatric patients with sickle cell disease at King Saud Medical City in Riyadh, Saudi Arabia","volume":"41","author":"Azmet FR","year":"2020","unstructured":"Azmet FR, Al-Kasim F, Alashram WM, Siddique K. The role of hydroxyurea in decreasing the occurrence of vasso-occulusive crisis in pediatric patients with sickle cell disease at King Saud Medical City in Riyadh, Saudi Arabia. Saudi Med J. 2020, 41:46-52. 10.15537\/smj.2020.1.24698","journal-title":"Saudi Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21699","article-title":"The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up","volume":"85","author":"Steinberg MH","year":"2010","unstructured":"Steinberg MH, McCarthy WF, Castro O, et al.. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up. Am J Hematol. 2010, 85:403-8. 10.1002\/ajh.21699","journal-title":"Am J Hematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/joah.joah_67_19","article-title":"Epidemiology and characteristics of sickle cell patients admitted to hospitals in Jazan region, Saudi Arabia","volume":"11","author":"Hazzazi AA","year":"2020","unstructured":"Hazzazi AA, Ageeli MH, Alfaqih AM, Jaafari AA, Malhan HM, Bakkar MM. Epidemiology and characteristics of sickle cell patients admitted to hospitals in Jazan region, Saudi Arabia. J Appl Hematol. 2020, 11:10-4. 10.4103\/joah.joah_67_19","journal-title":"J Appl Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/167533-frequency-of-painful-crisis-and-other-associated-complications-of-sickle-cell-anemia-among-children","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:35Z","timestamp":1707509315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/167533-frequency-of-painful-crisis-and-other-associated-complications-of-sickle-cell-anemia-among-children"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.48115","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}